RE: CE mark10 May 2021 14:01
The statement below will be enough to convert the test into a massive commercial opportunity..
Avacta's AffiDX® antigen test. As part of the recent clinical study the same clinical samples were tested with two leading, commercially available lateral flow antigen tests, and the data show that the AffiDX® test had better clinical sensitivity across the range of Ct values tested and, in particular, at lower viral loads.